Another CDK4/6 Inhibitor Boosts PFS in Breast Cancer Abemaciclib-fulvestrant combo for advanced HR+/HER2- disease Jun 08, 2017
No Survival Benefit with Node Dissection in Ovarian Ca Macroscopic complete resection drives outcomes Jun 07, 2017
Two Anti-HER2 Drugs Slightly Better Than One Patient selection key to addition of pertuzumab to trastuzumab Jun 07, 2017
Genomic Testing Helps Cancer Patients -- When Results are Used Also, liquid biopsy can ID drug-responsive tumors Jun 06, 2017
Dacomitinib Sets PFS Record in Phase III NSCLC Trial Next-gen EGFR inhibitor wins head-to-head battle with gefitinib, at least for efficacy Jun 06, 2017
Immunotherapy Shows Promise in Tough-to-Treat Mesothelioma Outcomes improved with nivolumab alone or with ipilimumab in pretreated patients Jun 05, 2017
Advanced Ca Patients Benefit from Online Symptom Reports Patient-reported outcomes tied to increased survival Jun 05, 2017
Trastuzumab Copycat Has Similar Efficacy Phase III trial compared substances in early-stage breast cancer Jun 05, 2017
Big Win for PARP Inhibitor in Breast Cancer PFS boost for HER2-negative, BRCA-mutated disease Jun 05, 2017
Morning Break: Tainted Trials; $40K/Yr Concierge Practice; Reality TV: Diabetes Health news and commentary from around the Web gathered by the Ƶ staff Jun 05, 2017
Short-Course RT Helps Retain Ability to Walk in Advanced Ca Preferable to multi-dose radiotherapy for spinal cord compression Jun 04, 2017
Novel Agent Shows Antitumor Activity in TRK-Fusion Cancers Tumor genetics define treatment approach in early-stage trials Jun 04, 2017
Mixed Results with Novel Tx in Sarcoma Aldodoxorubicin can't boost PFS, but promising in L-sarcomas Jun 03, 2017
Abiraterone Combo: A New Care Standard in Prostate Cancer? Earlier treatment appears to improve survival in metastatic disease Jun 03, 2017
Second Surgery Slows Recurrent Ovarian Cancer But no survival gain seen in interim analysis of DESKTOP III Jun 03, 2017
Psychosocial Interventions Help Cancer Patients Cope Programs focus on lowering fear of recurrence, managing advanced disease Jun 03, 2017
Cancer Biology: Getting Down to Basics with Bob Weinberg The synergy between science and carpentry May 23, 2017
'A Very Dangerous Interpretation': What We Heard This Week Quotable quotes from Ƶ's sources May 19, 2017
ASCO: Healthy Lifestyle Adds to Colon Cancer Survival Study results should not be interpreted as substitutes for standard care May 17, 2017
Asthma Biologic, Rally Among ATS Highlights Attendees to organize on Capitol Hill; will also hear benralizumab phase III results May 17, 2017
PSA Testing: Docs Walk the Screening Talk Physicians likely to undergo screening themselves May 13, 2017
Video Capsule Endoscopy Proves Useful in PJS Patients Peutz-Jeghers Syndrome carries increased risk for bowel neoplasia May 10, 2017
Robotically Controlled Capsule Scope Passes Early Tests Tethered capsule can perform complex intracolonic maneuvers automatically May 10, 2017
ESTRO: Survival in Pancreatic Ca Rises with RT Dose Also: cartoons during RT, brachytherapy for penile cancer May 08, 2017
ESTRO: Tumor-Adapted RT Lowers Pneumonitis in Lung Cancer Selected presentations from the European RT meeting May 07, 2017
ORBIT Score Pinpoints Repeat GI Bleeds with Anticoagulation Patients rated as high risk show greater rates of rebleeding May 07, 2017
Should Repeat FNA for Thyroid Nodules Again Be Recommended? A systematic review and meta-analysis reported a 98% NPV for repeat FNA May 04, 2017
A Better Way to Define ALL Remission? Can minimal residual disease (MRD) replace morphology for determining disease remission? May 01, 2017
Wise Buy? Focused Ultrasound Therapies Exciting technology, but now sold to patients on slim supporting evidence Apr 28, 2017
Liver Cancer Tx with Radioactive Beads Yields Mixed Results No survival benefit but quality of life better Apr 23, 2017
Can Your Furniture Give You Thyroid Cancer? Household flame retardants tied to disease occurrence, severity Apr 03, 2017
NCCN Guideline: No Ink on Tumor Suffices in Breast Cancer Tx New NCCN guidelines discourage centimeter-wide margins Mar 27, 2017
NCCN: Checkpoint Inhibitors an Option for Bladder Cancer Results from phase II studies strong enough in advanced disease Mar 27, 2017